Literature DB >> 33891671

Polymyxin Acute Kidney Injury: a case of severe tubulopathy.

Lucas Alexandre de Mello Goldin1, Leticia Nicoletti Silva1, Thiago Florencio da Silva1, Vinicius Daher Alvares Delfino1,2,3.   

Abstract

Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed polymyxin B to treat a surgical wound infection, which led to significant increases in fractional excretion of calcium, magnesium, and potassium and subsequent persistent decreases in the levels of these ions, with serious consequences for the patient. Severe hypocalcemia, hypomagnesemia, and hypokalemia may occur during treatment with polymyxin. Calcium, magnesium and potassium serum levels must be monitored during treatment to prevent life-threatening conditions.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 33891671      PMCID: PMC8943871          DOI: 10.1590/2175-8239-JBN-2019-0191

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  14 in total

Review 1.  Hypomagnesemia.

Authors:  Z S Agus
Journal:  J Am Soc Nephrol       Date:  1999-07       Impact factor: 10.121

Review 2.  Magnesium Handling in the Kidney.

Authors:  Joshua N Curry; Alan S L Yu
Journal:  Adv Chronic Kidney Dis       Date:  2018-05       Impact factor: 3.620

Review 3.  Adverse reactions associated with systemic polymyxin therapy.

Authors:  Julie Ann Justo; John A Bosso
Journal:  Pharmacotherapy       Date:  2014-09-30       Impact factor: 4.705

Review 4.  Drug-induced nephrotoxicity.

Authors:  Gabriel Teixeira Montezuma Sales; Renato Demarchi Foresto
Journal:  Rev Assoc Med Bras (1992)       Date:  2020-01-13       Impact factor: 1.209

5.  Fractional excretion of potassium in normal subjects and in patients with hypokalaemia.

Authors:  M Elisaf; K C Siamopoulos
Journal:  Postgrad Med J       Date:  1995-04       Impact factor: 2.401

6.  How does colistin-induced nephropathy develop and can it be treated?

Authors:  Gulsum Ozkan; Sukru Ulusoy; Asim Orem; Mehmet Alkanat; Sevdegül Mungan; Esin Yulug; Fulya Balaban Yucesan
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

Review 7.  Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?

Authors:  Alexandre P Zavascki; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

Review 8.  [Polymyxins - review with emphasis on nephrotoxicity].

Authors:  Carlos Alberto Caldeira Mendes; Emmanuel A Burdmann
Journal:  Rev Assoc Med Bras (1992)       Date:  2009 Nov-Dec       Impact factor: 1.209

Review 9.  Nephrotoxicity of Antimicrobials and Antibiotics.

Authors:  Martha Catalina Morales-Alvarez
Journal:  Adv Chronic Kidney Dis       Date:  2020-01       Impact factor: 3.620

10.  Significant accumulation of polymyxin in single renal tubular cells: a medicinal chemistry and triple correlative microscopy approach.

Authors:  Mohammad A K Azad; Kade D Roberts; Heidi H Yu; Boyin Liu; Alice V Schofield; Simon A James; Daryl L Howard; Roger L Nation; Kelly Rogers; Martin D de Jonge; Philip E Thompson; Jing Fu; Tony Velkov; Jian Li
Journal:  Anal Chem       Date:  2015-01-15       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.